246 related articles for article (PubMed ID: 9154942)
1. Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1997 May; 36(18):5578-88. PubMed ID: 9154942
[TBL] [Abstract][Full Text] [Related]
2. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
[TBL] [Abstract][Full Text] [Related]
3. 5'-Diphosphoadenosine 3'-phosphate is a potent inhibitor of bovine pancreatic ribonuclease A.
Russo N; Shapiro R; Vallee BL
Biochem Biophys Res Commun; 1997 Feb; 231(3):671-4. PubMed ID: 9070868
[TBL] [Abstract][Full Text] [Related]
4. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
Leonidas DD; Chavali GB; Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Vlassi M; Frankling C; Acharya KR
Protein Sci; 2003 Nov; 12(11):2559-74. PubMed ID: 14573867
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
Kobe B; Deisenhofer J
J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
[TBL] [Abstract][Full Text] [Related]
6. Computer modeling studies of ribonuclease T1-guanosine monophosphate complexes.
Balaji PV; Saenger W; Rao VS
Biopolymers; 1990; 30(3-4):257-72. PubMed ID: 2177661
[TBL] [Abstract][Full Text] [Related]
7. Unexpected binding mode for 2'-phosphoadenosine-based nucleotide inhibitors in complex with human angiogenin revealed by heteronuclear NMR spectroscopy.
Tonan K; Xu P; Jenkins JL; Russo A; Shapiro R; Ni F
Biochemistry; 2003 Sep; 42(38):11137-49. PubMed ID: 14503864
[TBL] [Abstract][Full Text] [Related]
8. The binding of IMP to ribonuclease A.
Hatzopoulos GN; Leonidas DD; Kardakaris R; Kobe J; Oikonomakos NG
FEBS J; 2005 Aug; 272(15):3988-4001. PubMed ID: 16045769
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of ribonuclease F1 of Fusarium moniliforme in its free form and in complex with 2'GMP.
Vassylyev DG; Katayanagi K; Ishikawa K; Tsujimoto-Hirano M; Danno M; Pähler A; Matsumoto O; Matsushima M; Yoshida H; Morikawa K
J Mol Biol; 1993 Apr; 230(3):979-96. PubMed ID: 8386773
[TBL] [Abstract][Full Text] [Related]
11. Ionic interactions in crystalline bovine pancreatic ribonuclease A.
Fedorov AA; Joseph-McCarthy D; Fedorov E; Sirakova D; Graf I; Almo SC
Biochemistry; 1996 Dec; 35(50):15962-79. PubMed ID: 8973167
[TBL] [Abstract][Full Text] [Related]
12. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
[TBL] [Abstract][Full Text] [Related]
13. The binding of 3'-N-piperidine-4-carboxyl-3'-deoxy-ara-uridine to ribonuclease A in the crystal.
Leonidas DD; Maiti TK; Samanta A; Dasgupta S; Pathak T; Zographos SE; Oikonomakos NG
Bioorg Med Chem; 2006 Sep; 14(17):6055-64. PubMed ID: 16730994
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
[TBL] [Abstract][Full Text] [Related]
15. Multiple solvent crystal structures of ribonuclease A: an assessment of the method.
Dechene M; Wink G; Smith M; Swartz P; Mattos C
Proteins; 2009 Sep; 76(4):861-81. PubMed ID: 19291738
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure reveals two alternative conformations in the active site of ribonuclease Sa2.
Sevcík J; Dauter Z; Wilson KS
Acta Crystallogr D Biol Crystallogr; 2004 Jul; 60(Pt 7):1198-204. PubMed ID: 15213380
[TBL] [Abstract][Full Text] [Related]
17. Temperature dependence of the backbone dynamics of ribonuclease A in the ground state and bound to the inhibitor 5'-phosphothymidine (3'-5')pyrophosphate adenosine 3'-phosphate.
Kovrigin EL; Cole R; Loria JP
Biochemistry; 2003 May; 42(18):5279-91. PubMed ID: 12731869
[TBL] [Abstract][Full Text] [Related]
18. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
[TBL] [Abstract][Full Text] [Related]
19. A potential allosteric subsite generated by domain swapping in bovine seminal ribonuclease.
Vitagliano L; Adinolfi S; Sica F; Merlino A; Zagari A; Mazzarella L
J Mol Biol; 1999 Oct; 293(3):569-77. PubMed ID: 10543951
[TBL] [Abstract][Full Text] [Related]
20. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
Leonidas DD; Shapiro R; Allen SC; Subbarao GV; Veluraja K; Acharya KR
J Mol Biol; 1999 Jan; 285(3):1209-33. PubMed ID: 9918722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
